Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 8
2005 7
2006 5
2007 2
2008 5
2009 6
2010 19
2011 17
2012 15
2013 13
2014 13
2015 8
2016 13
2017 10
2018 12
2019 12
2020 8
2021 12
2022 11
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells.
Maxwell S, Okabe J, Kaipananickal H, Rodriguez H, Khurana I, Al-Hasani K, Chow BSM, Pitsillou E, Karagiannis TC, Jandeleit-Dahm K, Ma RCW, Huang Y, Chan JCN, Cooper ME, El-Osta A. Maxwell S, et al. Among authors: el osta a. J Am Soc Nephrol. 2024 Apr 17. doi: 10.1681/ASN.0000000000000345. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 38630537
Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients.
Vinci MC, Costantino S, Damiano G, Rurali E, Rinaldi R, Vigorelli V, Sforza A, Carulli E, Pirola S, Mastroiacovo G, Raucci A, El-Osta A, Paneni F, Pompilio G. Vinci MC, et al. Among authors: el osta a. Cardiovasc Diabetol. 2024 Mar 29;23(1):107. doi: 10.1186/s12933-024-02195-1. Cardiovasc Diabetol. 2024. PMID: 38553774 Free PMC article.
EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors.
Al-Hasani K, Marikar SN, Kaipananickal H, Maxwell S, Okabe J, Khurana I, Karagiannis T, Liang JJ, Mariana L, Loudovaris T, Kay T, El-Osta A. Al-Hasani K, et al. Among authors: el osta a. Signal Transduct Target Ther. 2024 Jan 1;9(1):2. doi: 10.1038/s41392-023-01707-x. Signal Transduct Target Ther. 2024. PMID: 38161208 Free PMC article.
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
Sourris KC, Ding Y, Maxwell SS, Al-Sharea A, Kantharidis P, Mohan M, Rosado CJ, Penfold SA, Haase C, Xu Y, Forbes JM, Crawford S, Ramm G, Harcourt BE, Jandeleit-Dahm K, Advani A, Murphy AJ, Timmermann DB, Karihaloo A, Knudsen LB, El-Osta A, Drucker DJ, Cooper ME, Coughlan MT. Sourris KC, et al. Among authors: el osta a. Kidney Int. 2024 Jan;105(1):132-149. doi: 10.1016/j.kint.2023.09.029. Epub 2023 Dec 8. Kidney Int. 2024. PMID: 38069998 Free article.
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus.
Khurana I, Howard NJ, Maxwell S, Du Preez A, Kaipananickal H, Breen J, Buckberry S, Okabe J, Al-Hasani K, Nakasatien S, Himathongkam T, Cooper ME, Maple-Brown L, Thewjitcharoen Y, Brown A, El-Osta A. Khurana I, et al. Among authors: el osta a. Diabetes Res Clin Pract. 2023 Oct;204:110918. doi: 10.1016/j.diabres.2023.110918. Epub 2023 Sep 24. Diabetes Res Clin Pract. 2023. PMID: 37748713 Free article.
194 results